BlueRock's Phase I study with bemdaneprocel in patients with Parkinson's disease meets primary endpoint
Phase One clinical trial advances stem ce... - Cure Parkinson's
Phase One clinical trial advances stem cell therapy for Parkinson's. Could this be the basis for a cure?
Written by
jackedmonston
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE
https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=e4e0b40
Cure Parkinson’s and Van Andel Institute announce funding for a phase 1 clinical trial of low-dose lithium in Parkinson’s disease
Cure Parkinson’s and Van Andel Institute announce funding for a phase 1 clinical trial of...
The naturally occurring molecule N-acetylcysteine (NAC) shows benefit in a clinical trial for Parkinson's Disease.
N-acetylcysteine (NAC) is a naturally occurring molecule that replenishes one of the body's...
"First ever successful experimental stem cell therapy for Parkinson's Disease"
https://youtu.be/Cz_0T7A7xc4?si=X7X0UCasxigtSmPf
"Oct 9, 2023 #parkinsonsdisease...
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
This trial is already open in the United States, and I believe some on this forum are...
Related Posts
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
The "UP-study" phase 2 trial of UDCA Co funded by Cure Parkinson's led by Prof Oliver Bandmann
Phase 3 Positive Topline Results for Tavapadon - Approved Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson's Disease Patients Worldwide in Japan
Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered
